Cargando…

Outcome of severe community-acquired pneumonia: the impact of comorbidities

Detalles Bibliográficos
Autores principales:	Pereira, JM, Paiva, JA, Froes, F, Baptista, JP, Gonçalves-Pereira, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642891/ http://dx.doi.org/10.1186/cc11979

Ejemplares similares

Severe community-acquired pneumonia: risk factors for in-hospital mortality
por: Pereira, JM, et al.
Publicado: (2012)

Severe community-acquired pneumonia in the intensive care unit
por: Costa, C, et al.
Publicado: (2005)

Middle molecules in severe community-acquired pneumonia
por: Dumitras, T, et al.
Publicado: (2015)

Prognostic assessment in community-acquired pneumonia by pneumonia severity scores and biomarkers
por: Dusemund, F, et al.
Publicado: (2010)

Mathematical modeling of community-acquired pneumonia patients
por: Sarkar, J, et al.
Publicado: (2009)

Defining severe community-acquired pneumonia: a significant barrier to improving patient outcomes
por: Balp, MM, et al.
Publicado: (2009)

Racial disparities in quality of care in community-acquired pneumonia
por: Mayr, FB, et al.
Publicado: (2008)

Severity of illness scoring systems in community-acquired Legionella pneumonia
por: Simonsen, Ø, et al.
Publicado: (2010)

Severe pneumonia in critically ill cancer patients: clinical outcomes and a comparison between healthcare-associated pneumonia and community-acquired pneumonia
por: Rabello, Ligia SCF, et al.
Publicado: (2013)

A new severity score for community-acquired pneumonia: PARB score
por: Uchiyama, N, et al.
Publicado: (2010)

Impact of the adequacy of antibiotic therapy on the outcome of ventilator-associated pneumonia
por: Goncalves-Pereira, J, et al.
Publicado: (2011)

Age-related differences of outcomes in patients hospitalized with community-acquired pneumonia are not explained by differences in immune response
por: Kale, S, et al.
Publicado: (2010)

Coagulation in hospitalized community-acquired pneumonia: disturbances in even the least ill
por: Reade, MC, et al.
Publicado: (2008)

Community-acquired pneumonia treated on the ICU
por: Apostolidou, E, et al.
Publicado: (2006)

Analysis of the mortality rate in patients admitted to the ICU for severe community-acquired pneumonia
por: Joya-Montosa, C, et al.
Publicado: (2015)

Association of C-Reactive Protein and Outcome in Patients With Community-Acquired Pneumonia
por: Park, JK, et al.
Publicado: (2015)

Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia
por: Suberviola, B, et al.
Publicado: (2011)

Effects of systemic steroid in patients with severe community-acquired pneumonia requiring mechanical ventilation
por: Chon, G, et al.
Publicado: (2009)

Assessment of specific risk scores for patients admitted to the ICU for severe community-acquired pneumonia
por: Joya-Montosa, C, et al.
Publicado: (2015)

Systemic corticosteroids for community-acquired pneumonia in adults
por: Pugh, RJ, et al.
Publicado: (2012)

Comorbidities impact on the prognosis of severe acute community-acquired pneumonia
por: Vidal, Ana, et al.
Publicado: (2017)

Host genetic variants associated with community-acquired pneumonia
por: Salnikova, LE, et al.
Publicado: (2013)

Association of prior statin therapy with cytokine profiles and outcomes in patients hospitalized with community acquired pneumonia
por: Milbrandt, E, et al.
Publicado: (2005)

Validation of predictive rules for ICU patients with community-acquired pneumonia
por: Rudnov, V, et al.
Publicado: (2008)

Respiratory community-acquired and healthcare-related sepsis: are they different?
por: Castro, G, et al.
Publicado: (2008)

Criteria of the systemic inflammatory response syndrome in patients with community-acquired pneumonia
por: Ustyantseva, I, et al.
Publicado: (2006)

Portuguese network data: epidemiology of community-acquired sepsis
por: Carneiro, A, et al.
Publicado: (2006)

Community-acquired and healthcare-related urosepsis: a multicenter prospective study
por: Cardoso, T, et al.
Publicado: (2008)

Comparison of CURB-65 and CRB-65 as predictors of death in community-acquired pneumonia in adults admitted to an ICU
por: Santana, AR, et al.
Publicado: (2013)

Diabetes hinders community-acquired pneumonia outcomes in hospitalized patients
por: Martins, M, et al.
Publicado: (2016)

Pre-analytic factors and initial biomarker levels in community- acquired pneumonia patients
por: Kutz, A, et al.
Publicado: (2014)

Comparison of levofloxacin (L) and cefotaxime (C) combined with ofloxacin (O) for treatment of severe community-acquired pneumonia (CAP) in the intensive care unit
por: Leroy, O, et al.
Publicado: (2004)

Use of statins in community-acquired pneumonia in intensive care settings: is there a survival advantage?
por: Khanna, A, et al.
Publicado: (2011)

Beneficial effects of antiplatelet drugs in patients with community-acquired pneumonia and in endotoxin shock in mice
por: Winning, J, et al.
Publicado: (2007)

Gene expression in peripheral mononuclear cells from septic patients secondary to community-acquired pneumonia: patterns of gene expression and outcomes
por: Severino, P, et al.
Publicado: (2013)

Telavancin for the treatment of hospital-acquired pneumonia in severely ill and older patients: the ATTAIN studies
por: Rubinstein, E, et al.
Publicado: (2009)

Implementing national guidelines in intensive care patients with ventilator-associated, hospital-acquired, and healthcare-associated pneumonia: the IMPACT-HAP project
por: Kett, DH, et al.
Publicado: (2008)

Outcome of patients with initial non-mechanical ventilation management in severe pneumonia
por: Ortín, A, et al.
Publicado: (2015)

Simple and fast prediction of Legionella sp. in community-acquired pneumonia: validation of a prediction rule
por: Haubitz, S, et al.
Publicado: (2013)

1499. Incidence of Community Acquired Pneumonia by Age and Comorbid Conditions in the Veterans Health Administration (VHA)
por: Bej, Taissa A, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a4f37jk8cgkk21rc36t9797du5